216 Volume 26, Number 3
|
|
- Charity Cross
- 5 years ago
- Views:
Transcription
1 Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma Authors: Karla R. Kendrick, RN, MSN, Sunita C. Baxi, MD, and Robert M. Smith, MD, San Diego, Calif Introduction Rapid assessment and monitoring is essential for patients with acute bronchospasm. However, tools for measuring dyspnea or the state of being short of breath are often limited to peak flow, blood gas analysis, and asking patients multiple questions about their breathing at a time when they find speaking difficult. We thus decided to examine a tool called the modified Borg scale (MBS) that had the potential to provide quick, easy, and rapid information about a patient s subjective state of dyspnea. This 0 to 10 rated scale gave our ED patients a device they could use to measure and evaluate their dyspnea. For this reason, we added it to the triage assessment practice and included it in all posttreatment assessment notes on patients with exacerbations of asthma or chronic obstructive pulmonary disease (COPD) who were seen in the emergency department and urgent care clinic. Study questions (1) Can patients with acute bronchospastic asthma or COPD adequately communicate their level of dyspnea using the MBS? (2) Does subjective improvement in the patient s dyspnea using the MBS correlate with improvements in pulmonary functions as measured by the peak flow meter and cutaneous oxygen saturation (SaO 2 )? Methods Routine and triage assessment of subjective dyspnea using the MBS was instituted at a hospital emergency department serving adult veterans. Concurrently, the MBS was added to our standardized treatment protocol for management of patients with bronchospasm. ED and urgent care records were reviewed to collect baseline and postrespiratory treatment data on peak expiratory flow rates (PEFR), MBS scores, and SaO 2 percentages. Karla R. Kendrick, San Diego County Chapter, is Staff Nurse III and Quality Improvement Facilitator for the Emergency Department and Urgent Care Clinic, Veterans Administration San Diego HealthCare System, San Diego, Calif; Karlak@ix.netcom.com. Sunita C. Baxi is a staff physician in the Section of General Internal Medicine and Geriatrics, Veterans Administration San Diego HealthCare System, and Associate Clinical Professor of Medicine at UCSD, San Diego, Calif. Robert M. Smith is Associate Chief of Staff for Health Care Analysis at Veterans Administration San Diego HealthCare System and Associate Clinical Professor of Medicine at UCSD, San Diego, Calif. For reprints, write: Karla R. Kendrick, RN, MSN, 4982 Marin Dr, Oceanside, CA Copyright 2000 by the Emergency Nurses Association /2000 $ /1/ doi: /men Results Four hundred male veterans aged 24 to 87 years presented with a chief complaint of dyspnea. The assessing physician identified 102 of these patients as having acute bronchospasm; 42 were diagnosed with asthma, and 60 were diagnosed with COPD. All study patients with acute bronchospasm were able to use the MBS to rate their perception of severity of dyspnea. As the peak flow measurements increased, the MBS scores of difficulty breathing decreased. For the asthma groups, the mean MBS score decreased from 5.1 at triage baseline to 2.4 after treatment. This finding indicated that a significant correlation existed between the change in MBS scores and the change in PEFR from pretreatment to posttreatment scores (r =.31, P <.05). As the peak flow increased, the MBS scores decreased. SaO 2 only slightly improved in the asthma group compared with the COPD group. For patients with COPD, the mean MBS score decreased from 6.0 at triage baseline to 3.0 after treatment. This finding indicated that a significant correlation also existed between the change in MBS scores and the change in PEFR from pretreatment to posttreatment scores (r =.42, P <.001). Cutaneous oxygen saturation also improved in the COPD group after treatment. The modality of treatment ordered by the physician was metered dose inhaler or nebulizer. These treatment modalities had no effect on the aforementioned results in the asthma or COPD group. Conclusions The MBS is a valid and reliable assessment tool for dyspnea. This study demonstrated that it correlated well with other clinical parameters and could be useful when assessing and monitoring outcomes in patients with acute bronchospasm. Patients who used the MBS rated it with a high degree of satisfaction on ease of use and found that the language in this scale adequately expressed their dyspnea. The ED triage and primary care nursing staff rated the MBS as highly satisfactory, stating that it was quick and easy to use. Respiratory assessment in the triage notes and nursing notes were streamlined to consistently include 3 respiratory measures: PEFR, MBS, and SaO 2. Long respiratory narratives were found to be unnecessary in many cases. In addition, the MBS helped to include an important element of subjective assessment when evaluating the severity of dyspnea. (J Emerg Nurs 2000;26:216-22) 216 Volume 26, Number 3
2 Kendrick, Baxi, and Smith/JOURNAL OF EMERGENCY NURSING Figure 1 Modified Borg scale. (Note: The word breathlessness was added in our version of the scale for clarification.) (From Burdon JGW, Juniper EF, Killian KJ, Hargrave FE, Campbell EJM. The perception of breathlessness in asthma. Am Rev Respir Dis 1982;126: Official Journal of the American Thoracic Society. by the American Lung Association.) The symptom of shortness of breath or dyspnea is one of the most common and significant complaints of patients with respiratory disease. The sensation of dyspnea is a sensory experience that is perceived, interpreted, and rated by the individual. 1-3 The nursing narrative assessment of a patient who comes to the emergency department with dyspnea usually includes counting the respiratory rate, characterizing the rhythm of respiration, and identifying the use of accessory muscles of respiration, skin color, the ability to speak in full sentences, and what triggered this episode. 4,5 Many nurses still use the question/answer type of narrative in their respiratory assessment and require patients to answer such questions as How far can you walk? and What relieves your shortness of breath? even if the patients are having great difficulty breathing. Many triage nurses have included additional objective information in their assessment, such as peak expiratory flow rate (PEFR) or forced expiratory volume (FEV 1 ) and/or cutaneous oxygen saturation measurement (SaO 2 ). However, ED patients are not routinely asked to actively participate in rating their dyspnea by either the ED nurse or the ED physician. Subjective assessment of dyspnea was not mentioned in the recent National Institutes of Health expert panel report for the diagnosis and management of asthma. 6 In sharp contrast, if a patient comes to the emergency department with chest or abdominal pain, the patient is often asked to rate his or her pain on a scale of 1 to 10. After assessing the origin of the pain, medication is ordered and administered on the basis of the patient s subjective pain response. We wanted to study whether a similar self-rating scale could be used for patients with varying levels of dyspnea. If such a scale is useful, how accurate is it? The literature includes a variety of studies that have attempted to understand how patients measure the sensation of dyspnea or shortness of breath. 1,7,8 Burdon et al. 9 used the modified Borg scale (MBS) with a group of patients with asthma to determine their perceived dyspnea as it related to specific pulmonary changes in air flow obstruction. These patients were shown the MBS, which is a vertical scale from 0 to 10 in which numbers are anchored with corresponding verbal expressions of progressively increasing intensity. The patients were asked to rate their dyspnea by selecting the number with the corresponding words that most appropriately described their sensation of breathlessness (Figure 1). Belman et al 10 found that the MBS was a reliable tool for quantifying dyspnea in subjects with COPD who were undergoing a 6-minute treadmill walk. Simon et al. 11 found that when patients were asked to June
3 JOURNAL OF EMERGENCY NURSING/Kendrick, Baxi, and Smith Figure 2 Protocol for management of patients with acute bronchospasm at the Emergency Department and Urgent Care Clinic at the VA San Diego HealthCare System, San Diego, Calif. describe their symptoms of breathlessness, they used a variety of expressions such as out of breath, can t breath, or chest tightness, which suggested that each patient was having a different sensory experience rather than a single experience. Using normal volunteers, Simon et al. 9 tested whether persons with induced dyspnea could distinguish between levels of breathlessness using the MBS. Their study found that subjects could distinguish between different sensations of breathlessness and that the term breathlessness may encompass multiple sensations. A study by Mador et al 12 measured dyspnea in patients with COPD during a 5-week exercise program. These investigators reported a strong linear relationship between MBS ratings and respiratory effort when combined with exercise. Wilson and Jones 13 compared use of a visual analogue scale and the MBS to measure dyspnea in healthy young volunteers during exercise. These investigators similarly reported that good correlation exists between the intensity of breathlessness described by MBS and the amount of work done during exercise. The literature review clearly showed that the MBS was a valid and reliable tool when used in pulmonary medicine and in exercise physiology studies. However, no data existed on its effectiveness when used as a triage and ongoing assessment tool in the emergency department. This study was conducted to test whether dyspnea as reported by ED patients with acute bronchospasm could accurately reflect their degree of cardiopulmonary dysfunction, as measured by the PEFR and 218 Volume 26, Number 3
4 Kendrick, Baxi, and Smith/JOURNAL OF EMERGENCY NURSING Figure 3 The response to therapy measured by the peak expiratory flow rate (PEFR) in the asthma and COPD group demonstrated that both groups had an increase in peak flow from pretreatment to posttreatment. No significant degree of change in the patients PEFR reading occurred when they were treated with a metered dose inhaler with spacer device (MDI) compared with a handheld nebulizer (NEB). Figure 4 The response to therapy measured by modified Borg scale (MBS) in the asthma and COPD group revealed that dyspnea scores decreased after respiratory treatments. No significant degree of change occurred in the patients MBS scores when they were treated with meter dose inhaler with spacer device (MDI) compared with a handheld nebulizer (NEB). SaO 2. Although subjective symptoms can be misleading, we hypothesized that a subjective component of pulmonary function exists that can be measured, and we believed that the principle of self-rating to describe the degree of dyspnea could be an important link in quantifying the complex feeling of being short of breath or having dyspnea in the acute environment. To determine the effectiveness of the MBS, we asked 2 questions: (1) Can patients with acute bronchospastic asthma or COPD adequately communicate their level of dyspnea using the MBS? (2) Does subjective improvement in the patient s breathlessness using the MBS correlate with improvements in pulmonary function as measured by the peak flow meter and SaO 2? Methods This retrospective chart review study was conducted at the emergency department and urgent care clinic at the VA San Diego Health Care System in San Diego, Calif. The MBS was added to the clinical protocol for management of patients with acute bronchospasm (Figure 2). According to the protocol, the MBS was administered by the triage nurse and again 30 minutes after respiratory treatments. The MBS procedure was explained to patients by the triage nurse and recorded as a fraction (patients rating number over the total possible; for example, 5/10). An attending physician evaluated all patients and ordered β 2 -agonist albuterol with anticholinergic agent ipratropium bromide delivered by either metered dose inhaler (MDI) with a spacer device or a handheld nebulizer (NEB). Patients with a complaint of dyspnea were selected based on review of the ED log. Among those with dyspnea, patients who met the following criteria were included in this study: (1) they had a history of asthma or COPD and were not oxygen dependent, (2) they received emergent treatment for bronchospasm and were diagnosed with either asthma or COPD, and (3) they were discharged from the emergency department to home after receiving treatment. Demographic information was limited to age and gender. A 3- way analysis of variance was used to examine the effect of diagnosis, treatment modality, and time on MBS, PEFR, and SaO 2. Next we examined the relationships between the change in PEFR readings and the change in MBS scores with treatment. We also examined whether there was a change in SaO 2 percentage and a change in MBS scores, which were analyzed by linear regression using the Pearson correlation coefficient (r). Changes were considered to be significant when P was less than.05. To describe the prescores and postscores (change scores), we looked at the relationship between the intensity of breathlessness scores June
5 JOURNAL OF EMERGENCY NURSING/Kendrick, Baxi, and Smith 199), bronchitis (n = 29), congestive heart failure (n = 33), and pneumonia (n = 37). Participants were all men between the ages of 24 and 87 (mean age, 59 years). Forty-two patients were diagnosed with asthma and 60 had COPD. The attending ED physician evaluated all patients after they were triaged and ordered β 2 -agonist albuterol with ipratropium bromide delivered by either a handheld nebulizer or a metered dose inhaler through a spacer device according to the protocol (Figure 2). Figure 5 The response to therapy measured by cutaneous oxygen saturation (SaO 2 ) in the asthma and COPD group increased from before to after respiratory treatment. A greater increase in SaO 2 occurred in the COPD than in the asthma group; concurrently, the post COPD group had slightly higher SaO 2 percentages when using a handheld nebulizer (NEB) than when using a metered dose inhaler with spacer device (MDI). and PEFR and between breathlessness scores and SaO 2 readings before and after therapy. Data are presented as mean ± SEM. Triage Patients who had a chief complaint of being short of breath or of experiencing dyspnea were shown an enlarged copy of the MBS and were asked to rate their dyspnea (Figure 1). Documentation on the ED record by the triage nurse included the following: PEFR, personal best peak flow if known by the patient, SaO 2 in percentage, and MBS in fraction format with the patient rating listed over the maximum possible (eg, 5/10). Respiratory narratives were optional and left to the discretion of the individual triage nurse. If the patient had a known history of asthma or COPD, a copy of the protocol for management of patients with acute bronchospasm was attached to the ED record (Figure 2). All 102 patients who met inclusion criteria were able to communicate their level of dyspnea to the triage nurse using the enlarged MBS. Reassessment by the primary care nurse was also easily and uniformly accomplished using the aforementioned method following postrespiratory treatment. Results Of the 400 charts initially selected for complaint of dyspnea, 102 patients met the inclusion criteria. The patients who were excluded had diagnoses of flu (n = Response to therapy As expected by the pathophysiology of the underlying illness, analysis of variances revealed a greater effect of treatment on pulmonary function as assessed by PEFR in patients with asthma compared with those who had COPD (P <.0001). As has been suggested in other studies, there was no significant difference in the degree of change in the patients PEFR when treated with a handheld nebulizer compared with a metered-dose inhaler using a spacer device in either the asthma or COPD group (P =.24) (Figure 3). Dyspnea improved, as measured by a decrease in MBS from triage to discharge in both the asthma and COPD groups. This improvement was found to correlate well with the increase in overall PEFR (r = -0.42, P <.0001) (Figure 4). Again, the method of respiratory treatment (MDI with a spacer device versus handheld NEB) did not affect the magnitude of the change in MBS in either patient group (P =.29). Oxygen saturation increased with treatment in both the asthma group and the COPD group (P <.0001). A significantly greater increase in SaO 2 was found in the COPD group than in the asthma group (P =.0438); this greater increase in SaO 2 is attributed to the fact that the COPD group started at a lower percentage. It is interesting to note that the benefit of NEB over MDI using a spacer device was not found to be significant in either the asthma or COPD group (P =.1495) (Figure 5). Pearson correlation in the asthma group In the asthma patient group, the mean MBS rating decreased from 5.1 at baseline to 2.4 after treatment. The mean PEFR increased from 286 at baseline to 414 after treatment, and the mean SaO 2 increased minimally (from 95% to 96%). In the asthma group, there was a significant negative correlation between change score in MBS and change scores in the PEFR from prescores to postscores (r =.31, P <.05). As the peak flow score increased, the MBS score decreased; thus the better the patients peak flow scores, the lower the patients dyspnea ratings. Similarly, there was a significant negative correlation between change in scores in MBS and the 220 Volume 26, Number 3
6 Kendrick, Baxi, and Smith/JOURNAL OF EMERGENCY NURSING change in pulse oximetry readings (r =.26, P <.05). As the MBS score decreased, the SaO 2 increased. Pearson correlation in the COPD group In the COPD group, the mean MBS decreased from 6.0 at baseline to 3.0 after treatment. Over the same interval, the mean PEFR increased from 183 to 252 and the mean oxygen saturation increased from 92% to 94% on room air. In the COPD group, there was a significant negative correlation between the change scores in MBS and change in PEFR from prescores to postscores (r =.42, P <.001). However, there was no correlation between change in MBS and the change in SaO 2 readings (r =.10, P <.30) in the COPD group. This finding was attributed to the fact that members of the COPD group were in varying states of hypoxia when oxygen saturation readings were taken. An interesting finding was that in the COPD group oxygen saturation was slightly higher after nebulizer treatment than with MDI treatment with a spacer device (Figure 5). We offer no explanation for this finding other than to report it. Discussion Our data suggest that the MBS can be used in the emergency department as an accurate tool to measure subjective dyspnea in patients with acute bronchospasm. In addition, we demonstrated that it correlated well with other clinical parameters often used in the emergency department. An unintentional discovery in this study was that the type of respiratory treatment prescribed by the physician(s) did not influence the patients subjective rating of dyspnea. This fact further strengthened our belief that patient-rating tools could be a good indicator, regardless of the treatment used. Most emergency departments are continuing to look for means to quickly assess and deliver rapid treatment to patients with respiratory problems. However, unless a patient is exhibiting acute respiratory distress, we have no sliding scale for early recognition that the patient will need a treatment in X period of time after they arrive in the emergency department. Therefore, should not triage nurses use all the tools at their disposal, including the patient as an indicator? Our study has had the following results: We have taken the information learned from this study and have incorporated the MBS into our practice in the emergency department and urgent care clinic. We now use the MBS as a part of triage assessment. This information provides baseline data to measure the effectiveness of treatment(s). We use the MBS to triage patients with respiratory complaints and have found it to be especially useful in patients who are too dyspneic to perform objective testing such as peak flow. We found that the MBS is effective in assessing and monitoring treatments in both the nonacute and the acute environment. This has been a practical and effective way to provide documentation and continuity of care information between the two areas. We teach both patients and medical staff to use the MBS. It has provided a common language to describe the subjective sensation called dyspnea in measurable terms. We have also found the MBS to be useful in assessing patients with other acute or chronic medical problems (eg, congestive heart failure, pneumothorax, pneumonia, lung cancer, and/or chronic bronchitis). Our Telephone Advice nurses have found the MBS to be a valuable tool when interviewing and evaluating respiratory problems by phone. The Hospital Home Based Primary Care nursing staff have found the MBS to be an important adjunct tool when assessing patients with respiratory problems in their homes. In many cases, these homebound patients are unable to give an adequate peak expiratory effort to measure their PEFR, and portable cutaneous oxygen saturation devices are not usually available. Many of our ED attending physicians use the MBS baseline data obtained at the time of triage to assist in decision making regarding whether to continue respiratory treatment; these data are also used to make a decision about whether to discharge or admit the patient. Poststudy feedback Patients gave the MBS tool a high satisfaction rating on ease of use. They reported that the language used in the scale adequately expressed their dyspnea. Discharged ED and urgent care clinic patients were also given a laminated, wallet-sized copy of the MBS to use on return visits. The emergency triage and primary care nursing staff rated the MBS highly satisfactory and found it quick and easy to use. Triage respiratory assessment notes and nursing notes were streamlined to include primarily the PEFR, MBS, and SaO 2. Time-consuming and detailed respiratory narratives were found to be unnecessary in most cases. The triage nurse and primary nurses also indicated that adding the MBS to the triage notes added another dimension when evaluating the level of acuity and/or treatment needs for each patient. June
7 JOURNAL OF EMERGENCY NURSING/Kendrick, Baxi, and Smith We are also looking into a means of adopting the use of the initials MBS to document dyspnea. We believe that MBS could be easily integrated into hospitals and clinics as an accepted abbreviation. Conclusion This study was limited to a relatively small group of adult men with bronchospasm who were treated and released from an emergency department or urgent care clinic. An expanded study with a general population might reveal even higher correlation scores and could generate valuable outcome measures that could have a positive impact on how we assess, treat, and document the common sensory description of having dyspnea or shortness of breath. We believe that the MBS can be an invaluable clinical indicator for patients whose respiration is compromised. Today, health care models are incorporating tools that measure or evaluate outcome-based care. Nield and Patel 2 thought that respiratory tools can play an important role in maximizing positive outcomes from therapy. Using outcome-based measurements to guide health care delivery is spreading throughout the field of medicine, and most emergency departments are streamlining their protocols and treatment plans to reflect outcome-based care. Therefore, building on the standard of our nursing practice compels us to seek out tools that can measure and improve care. By incorporating the principles of self-rating, the patient is able to contribute valuable information to the medical and nursing treatment plan. Acknowledgment We thank Marty Shively, RN, PhD, for her endless support and encouragement. References 1. Elliott MW, Adams L, Cockcroft A, Macrae KD, Murrhy K, Guz A. The language of breathlessness. Am Rev Respir Dis 1991;144: Nield M, Kim MJ, Patel M. Use of magnitude estimation for estimating the parameters of dyspnea. Nurs Res 1989;38: Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14: Corbin AL. The patient with bronchospasm: assessment, triage, and teaching adjuncts. J Emerg Nurs 1992;18: Stromborg MF. Instruments of clinical nursing research. Boston: Jones & Bartlett Publishers; p National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma (NIH publication A). Washington: National Institutes of Health; Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest 1988;93: Harris D, Booker H, Rehaln M, Collins J. Measurement and perception of disability in chronic airways obstruction. Am Rev Respir Dis 1983;127(Suppl): Burdon JGW, Juniper EF, Killian KJ, Hargrave FE, Campbell EJM. The perception of breathlessness in asthma. Am Rev Respir Dis 1982;126: Belman MJ, Brooks LR, Ross DJ, Mohsenifar Z. Variability of breathlessness measurement in patients with chronic obstructive pulmonary disease. Chest 1991;99: Simon PM, Schwartzstein RM, Weiss JW, Lahive K, Fencl V, Teghtsoonian M, et al. Distinguishable sensation of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989;140: Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest 1995;107: Wilson RC, Jones PW. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnea during exercise. Clin Sci 1989;76: Volume 26, Number 3
Asthma Care in the Emergency Department Clinical Practice Guideline
Asthma Care in the Emergency Department Clinical Practice Guideline Inclusion: 1) Children 2 years of age or older with a prior history of wheezing, and 2) Children less than 2 years of age with likely
More informationEmergency Department Protocol Initiative
Emergency Department Protocol Initiative ACUTE ASTHMA MANAGEMENT TOOLKIT March 2006 Provincial Emergency Services Project PHYSICIAN ORDER TEMPLATE FOR CTAS LEVEL 1 ASTHMA ADULT PEDIATRIC Date: Site: Arrival
More informationPresented by UIC College of Nursing
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long-acting inhalers and emergency use inhalers.
More informationChronic Obstructive Pulmonary Disease 1/18/2018
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long acting inhalers and emergency use inhalers.
More informationLecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
More informationIntegrated Cardiopulmonary Pharmacology Third Edition
Integrated Cardiopulmonary Pharmacology Third Edition Chapter 13 Pharmacologic Management of Asthma, Chronic Bronchitis, and Emphysema Multimedia Directory Slide 7 Slide 12 Slide 60 COPD Video Passive
More informationManagement of acute asthma in children in emergency department. Moderate asthma
152 Moderate asthma SpO2 92% No clinical features of severe asthma NB: If a patient has signs and symptoms across categories, always treat according to their most severe features agonist 2-10 puffs via
More informationAsthma: Evaluate and Improve Your Practice
Potential Barriers and Suggested Ideas for Change Key Activity: Initial assessment and management Rationale: The history and physical examination obtained from the patient and family interviews form the
More informationRecommended Component: Manage Physical Activity for Students with Asthma
Recommended Component: Manage Physical Activity for Students with Asthma Individuals with exercise-induced asthma do not necessarily have other asthma triggers. For others with asthma, exercise may be
More informationONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS
R2 (REVISED MANUSCRIPT BLUE 200208-877OC) ONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS Mario Castro, M.D., M.P.H. Nina A. Zimmermann R.N. Sue
More informationNational Asthma Educator Certification Board Detailed Content Outline
I. THE ASTHMA CONDITION 9 20 1 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationRevision of 06/15/2018 Form #133 Page 1 of 4 PVDOMICS STUDY Six-Minute Walk Test Form #133
Revision of 06/15/2018 Form #133 Page 1 of 4 PVDOMICS STUDY Six-Minute Walk Test Form #133 Instructions: Review PVDOMICS MOP Chapter prior to completing participant s 6-minute walk test (6MWT). Borg Dyspnea
More informationNebulizer versus inhaler with spacer for beta-agonist treatment in acute bronchospastic disease
Hong Kong Journal of Emergency Medicine Nebulizer versus inhaler with spacer for beta-agonist treatment in acute bronchospastic disease β GPC Lee, WY Sung, HT Fung, CW Kam Objectives: To compare the efficacy
More informationRespiratory Emergencies. Chapter 11
Respiratory Emergencies Chapter 11 Respiratory System Anatomy and Function of the Lung Characteristics of Adequate Breathing Normal rate and depth Regular breathing pattern Good breath sounds on both sides
More informationSignificance. Asthma Definition. Focus on Asthma
Focus on Asthma (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Asthma Definition Chronic inflammatory disorder of airways Causes airway hyperresponsiveness
More informationMetered-Dose Inhaler With Spacer Instead of Nebulizer During the Outbreak of Severe Acute Respiratory Syndrome in Singapore
Metered-Dose Inhaler With Spacer Instead of Nebulizer During the Outbreak of Severe Acute Respiratory Syndrome in Singapore See Meng Khoo MBBS MMed, Lian Kheng Tan RN, Nora Said RN, and T K Lim MBBS BACKGROUND:
More informationWESTCHESTER REGIONAL EMERGENCY MEDICAL ADVISORY COMMITTEE
WESTCHESTER REGIONAL EMERGENCY MEDICAL ADVISORY COMMITTEE POLICY STATEMENT Supercedes/Updates: New No. 04-02 Date: April 19, 2004 Re: EMT-B Administration of Nebulized Albuterol Pages: 3 Administration
More informationPEDIATRIC ACUTE ASTHMA SCORE (P.A.A.S.) GUIDELINES. >97% 94% to 96% 91%-93% <90% Moderate to severe expiratory wheeze
Inclusion: Children experiencing acute asthma exacerbation 24 months to 18 years of age with a diagnosis of asthma Patients with a previous history of asthma (Consider differential diagnosis for infants
More informationPeak Expiratory Flow Rate (PEFR) for ED Management of Acute Asthma Exacerbation
Peak Expiratory Flow Rate (PEFR) for ED Management of Acute Asthma Exacerbation PI: Brian Driver, MD Checklist Reviewed Inclusion and Exclusion Criteria Confirm pertinent exclusion criteria with PMP Engage
More information2/12/2015. ASTHMA & COPD The Yin &Yang. Asthma General Information. Asthma General Information
ASTHMA & COPD The Yin &Yang Arizona State Association of Physician Assistants March 6, 2015 Sedona, Arizona Randy D. Danielsen, PhD, PA-C, DFAAPA Dean & Professor A.T. Still University Asthma General Information
More informationGINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017
GINA At-A-Glance Asthma Management Reference for adults, adolescents and children 6 11 years Updated 2017 This resource should be used in conjunction with the Global Strategy for Asthma Management and
More information2017 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2017 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2017 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationMSRC AIR Course Karla Stoermer Grossman, MSA, BSN, RN, AE-C
MSRC AIR Course Karla Stoermer Grossman, MSA, BSN, RN, AE-C Explain the importance of objective measures in the management of asthma Explain the different types of objective measures used in the management
More informationPathology of Asthma Epidemiology
Asthma A Presentation on Asthma Management and Prevention What Is Asthma? A chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Nighttime or early morning coughing Pathology
More informationCOPD Challenge CASE PRESENTATION
Chronic obstructive pulmonary disease (COPD) exacerbations may make up more than 10% of acute medical admissions [1], and they are increasingly recognised as a cause of significant morbidity and mortality
More informationPublic Dissemination
1. THE ASTHMA CONDITION 9 18 3 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationCourse Handouts & Disclosure
COPD: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Disclosure To download presentation
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationPULMONARY FUNCTION. VOLUMES AND CAPACITIES
PULMONARY FUNCTION. VOLUMES AND CAPACITIES The volume of air a person inhales (inspires) and exhales (expires) can be measured with a spirometer (spiro = breath, meter = to measure). A bell spirometer
More informationADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.
ADULT ASTHMA GUIDE SUMMARY This summary provides busy health professionals with key guidance for assessing and treating adult asthma. Its source document Asthma and Respiratory Foundation NZ Adult Asthma
More information1 Chapter 13 Respiratory Emergencies 2 Respiratory Distress Patients often complain about. Shortness of breath Symptom of many different Cause can be
1 Chapter 13 Respiratory Emergencies 2 Respiratory Distress Patients often complain about. Shortness of breath Symptom of many different Cause can be difficult to determine. Even for physician in hospital
More informationSt. Dominic Jackson Memorial Hospital. Pulmonary Services. Therapist Driven Protocol. Assess and Treat Aerosol Therapy
St. Dominic Jackson Memorial Hospital Pulmonary Services Therapist Driven Protocol Assess and Treat Aerosol Therapy Purpose The purpose of the Therapist Driven Protocol (TDP) aerosol therapy is to create
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationAsthma Management for the Athlete
Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric
More informationADASUVE (LOXAPINE) INHALATION POWDER. EDUCATION PROGRAM for HEALTHCARE PROFESSIONALS
ADASUVE (LOXAPINE) INHALATION POWDER EDUCATION PROGRAM for HEALTHCARE PROFESSIONALS August2017 December 2012 PMR-JUN-2017-0017 ADASUVE Risk Evaluation and Mitigation Strategy (REMS) Education Program Content
More informationSmall Volume Nebulizer Treatment (Hand-Held)
Small Volume Aerosol Treatment Page 1 of 6 Purpose Policy Physician's Order Small Volume Nebulizer Treatment To standardize the delivery of inhalation aerosol drug therapy via small volume (hand-held)
More informationDATE: 09 December 2009 CONTEXT AND POLICY ISSUES:
TITLE: Tiotropium Compared with Ipratropium for Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease: A Review of the Clinical Effectiveness DATE: 09 December 2009 CONTEXT AND POLICY
More informationProtocol Update 2019
Protocol Update 2019 There have been several questions revolving around protocol updates and how they are to be conducted. As many of you are aware there is a protocol submission process in the appendix
More informationAsthma Assessment & Review
ASTHMA RESOURCE PACK Section 5B Asthma Assessment & Review In this section: 1. Primary Care initial assessment and review Asthma Resource Pack Section 5B: Asthma Assessment & Review Version 3.0 Last Updated:
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationRESPIRATORY CARE IN GENERAL PRACTICE
RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they
More informationNEBULISERS AND NEBULISED MEDICATION. A Guide for the use of nebulisers and nebulised medication in the community setting
NEBULISERS AND NEBULISED MEDICATION A Guide for the use of nebulisers and nebulised medication in the community setting Aim This guide has been developed from the generic guidance circulated in April 2014.
More informationChronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease 07 Contributor Dr David Tan Hsien Yung Definition, Diagnosis and Risk Factors for (COPD) Differential Diagnoses Goals of Management Management of COPD THERAPY AT EACH
More informationASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides
BRONCHIAL ASTHMA ASTHMA Epidemiology Pathophysiology Diagnosis 2 CHILDHOOD ASTHMA Childhood bronchial asthma is characterized by Airway obstruction which is reversible Airway inflammation Airway hyper
More informationTreatment of Acute Asthma Exacerbations in Adults in the Primary Care or Urgent Care Setting Clinical Practice Guideline MedStar Health.
Treatment of Acute Asthma Exacerbations in Adults in the Primary Care or Urgent Care Setting Clinical Practice Guideline MedStar Health Background: These guidelines are provided to assist physicians and
More informationAssessment of respiratory outcome among patients with lower respiratory tract disorders
2018; 4(11): 196-200 ISSN Print: 2394-7500 ISSN Online: 2394-5869 Impact Factor: 5.2 IJAR 2018; 4(11): 196-200 www.allresearchjournal.com Received: 03-09-2018 Accepted: 04-10-2018 Surendran SR M.Sc (Medical
More informationEmergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE
Emergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE Indications for Vapotherm High Velocity Nasal Insufflation (Hi-VNI ) administration, the patient should be: Spontaneously
More informationMAYA RAMAGOPAL M.D. DIVISION OF PULMONOLOGY & CYSTIC FIBROSIS CENTER
MAYA RAMAGOPAL M.D. DIVISION OF PULMONOLOGY & CYSTIC FIBROSIS CENTER 16 year old female with h/o moderate persistent asthma presents to the ED after 6 hours of difficulty breathing, cough, and wheezing
More informationCOPD Management in LTC: Presented By: Jessica Denney RRT
COPD Management in LTC: Presented By: Jessica Denney RRT Sponsored by Z & D Medical Services, Diamond Sponsor Seizing Opportunities to Provide Individualized Treatment and Device Selection for your COPD
More information10/6/2014. Tommy s Story: An Overview of Asthma Mangement. Disclosure. Objectives for this talk.
Tommy s Story: An Overview of Asthma Mangement Clifton C. Lee, MD, FAAP, FHM Associate Professor of Pediatrics Chief, Pediatric Hospital Medicine Children s Hospital of Richmond at VCU Disclosure Obviously,
More informationAsthma in the Athlete
Asthma in the Athlete Jorge E. Gomez, MD Associate Professor Texas Children s Hospital Baylor College of Medicine Assist Team Physician UH Understand how we diagnose asthma Objectives Be familiar with
More informationBronchodilator Delivery and Nebuliser Trials in Adults
Bronchodilator Delivery and Nebuliser Trials in Adults Acute Management Favour the use of MDI (+/- Spacer) If considering nebuliser Short term treatment Approx. < 3 weeks See optimisation of inhaled bronchodilators
More informationRelevant Papers: eight relevant articles were found, but four were reviewed because they were most directly related to the topic
Topic: Prehospital use of bromide paired with salbutamol as treatment for shortness of breath. Author: Lisa Henderson Clinical Scenario: Two primary care paramedics respond code 4 for a 55 year old male
More information+ Asthma and Athletics
+ Asthma and Athletics Shaylon Rettig, MD, MBA Champion Sports Medicine + Financial Disclosure Dr. Shaylon Rettig has no relevant financial relationships with commercial interests to disclose. + Asthma
More informationOverview. The Respiratory System. Chapter 18. Respiratory Emergencies 9/11/2012
Chapter 18 Respiratory Emergencies Slide 1 Overview Respiratory System Review Anatomy Physiology Breathing Assessment Adequate Breathing Breathing Difficulty Focused History and Physical Examination Emergency
More information5/3/2012 PRESENTATION GOALS RESPIRATORY THERAPISTS ROLE IN END OF LIFE CARE FOR THE PULMONARY PATIENT
RESPIRATORY THERAPISTS ROLE IN END OF LIFE CARE FOR THE PULMONARY PATIENT Presented by Carrie Black Bourassa, LRT, RRT PRESENTATION GOALS Define palliative care Define hospice care Discuss pulmonary hospice
More informationPEDIATRIC ASTHMA INPATIENT CARE MAP
DATE PATIENT PEDIATRIC ASTHMA INPATIENT CARE MAP DOB HSC NO. PHIN Approved by the Winnipeg Regional Health Authority This Care Map is to be used as a guideline and in no way replaces sound clinical judgment
More informationMinimum Competencies for Asthma Care in Schools: School Nurse
Minimum Competencies for Asthma Care in Schools: School Nurse Area I. Pathophysiology 1. Explain using simple language and appropriate educational aids the following concepts: a. Normal lung anatomy and
More informationChapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators Clinical Indications for Use Indication for anticholinergic bronchodilator COPD maintenance Indication for combined anticholinergic and β-agonist
More informationUsing an Inhaler and Nebulizer
Using an Inhaler and Nebulizer Introduction An inhaler is a handheld device that is used to deliver medication directly to your airways. A nebulizer is an electric or battery powered machine that turns
More informationTHE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
More informationChronic Obstructive Pulmonary Disease Guidelines and updates
Chronic Obstructive Pulmonary Disease Guidelines and updates October 20, 2018 Saratoga Springs, NY COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United
More informationPulmonary Rehabilitation
Pulmonary Rehabilitation New Benefit The enactment of HR 6331, the Medicare Improvements for Patients and Providers Act of 2008, established a specific Medicare benefit for pulmonary rehabilitation. The
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
Page 1 of 9 PURPOSE To assure that DOP inmates with Pulmonary Diseases are receiving high quality Primary Care for their condition. POLICY All DOP Primary Care Providers and Chronic Disease Nurses are
More informationOverview of COPD INTRODUCTION
Overview of COPD INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a common lung disease that affects millions of people, and it is the fourth leading cause of death in the United States. It
More informationCOPD Diagnosis, Management and Program
COPD Diagnosis, Management and Program RYAN MARTIN, MD NEBRASKA PULMONARY SPECIALTIES Initial diagnosis Setting matters: Inpatient. Usually sicker, oftentimes avoiding healthcare. Outpatient. Often seeking
More informationJOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam
More informationStep-down approach in chronic stable asthma: A comparison of reducing dose Inhaled Formoterol/ Budesonide with maintaining Inhaled Budesonide.
Step-down approach in chronic stable asthma: A comparison of reducing dose Inhaled Formoterol/ Budesonide with maintaining Inhaled Budesonide. By: DR MOHD SHAMSUL AMRI Supervisor: Associate Professor Dr
More information6- Lung Volumes and Pulmonary Function Tests
6- Lung Volumes and Pulmonary Function Tests s (PFTs) are noninvasive diagnostic tests that provide measurable feedback about the function of the lungs. By assessing lung volumes, capacities, rates of
More informationA Guide for Students and Parents
A Guide for Students and Parents February 20, 2009 This program was made possible through an unrestricted grant from: Monaghan Medical Corporation, Lupin Pharmaceuticals Inc., and Forest Laboratories Inc.
More informationManagement of Respiratory Issues in the School Setting. Pediatric Indicators of High Risk 8/7/2015. Facts about Pediatric Respiratory Failure
Management of Respiratory Issues in the School Setting Toni B. Vento, MS, RN, NCSN Supervisor of Health Services Medford Public Schools Pediatric Indicators of High Risk Anatomic features of the immature
More informationM. Nield 1/24/2014. Research Team. Real-Time Telehealth for COPD Self- Management Using Skype. Guy W. Soo Hoo, MD MPH, West LA VA Co-Investigator
Real-Time Telehealth for COPD Self- Management Using Skype Margaret Nield PhD, RN, CNS - MS January 24, 214 Funded By: Breathe California of Los Angeles County & NIH/NINR P2 NR1671-3 Research Team Guy
More informationCOPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
More informationComparing COPD Treatment: Nebulizer, Metered Dose Inhaler, and Concomitant Therapy
The American Journal of Medicine (2007) 120, 435-441 CLINICAL RESEARCH STUDY Comparing COPD Treatment:, Metered Dose, and Concomitant Therapy Donald P. Tashkin, MD, a Gerald L. Klein, MD, b,c Shoshana
More informationKey words: computer administration; continuous method for rating breathlessness; exercise testing
Comparison of Continuous and Discrete Measurements of Dyspnea During Exercise in Patients With COPD and Normal Subjects* Gustavo Fierro-Carrion, MD; Donald A. Mahler, MD, FCCP; Joseph Ward, RCPT; and John
More informationTitle Protocol for the Management of Asthma
Document Control Title Protocol for the Management of Asthma Author Author s job title Professional Lead, Minor Injuries Unit Directorate Emergency Services, Logistics and Resilience Department Version
More informationPresented by the California Academy of Family Physicians 2013/California Academy of Family Physicians
Family Medicine and Patient-Centered Asthma Care Presented by the California Academy of Family Physicians Faculty: Hobart Lee, MD Disclosures: Jeffrey Luther, MD, Program Director, Memorial Family Medicine
More informationLearning Outcomes 1. Identify key U.S. drug regulations that have provided guidelines for the safe and effective use of drugs and drug therapy.
CHAPTER 2 DRUG APPROVAL AND REGULATION Learning Outcomes 1. Identify key U.S. drug regulations that have provided guidelines for the safe and effective use of drugs and drug therapy. Suggested Classroom
More informationBronchoconstriction is also treated with medications that inhibit bronchiolar constriction such as: Ipratropium (Atrovent)
Patients with difficulty breathing (dyspnea) may have problems with: Oxygenation due to alveolar problems Ventilation due to bronchiolar problems Oxygenation due to lung perfusion problems Combinations
More informationPathway Project Team
Semantic Components: A model for enhancing retrieval of domain-specific information Lecture 22 CS 410/510 Information Retrieval on the Internet Pathway Project Team Susan Price, MD Portland State University
More informationGlobal Initiative for Asthma (GINA) What s new in GINA 2015?
Global Initiative for Asthma (GINA) What s new in GINA 2015? GINA Global Strategy for Asthma Management and Prevention What s new in GINA 2015 (1) Add-on tiotropium by soft-mist inhaler is a new other
More informationIvax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence
Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence Clinical and cost-effectiveness of QVAR for the treatment of chronic asthma in adults and children
More informationA comparison of the visual analogue scale and modified Borg
Clinical Science ( 1989) 76,77-8 77 A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise RACHEL C. WILSON AND P. W. JONES Department of Medicine
More informationNIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
Introduction NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) Noninvasive ventilation (NIV) is a method of delivering oxygen by positive pressure mask that allows for the prevention or postponement of invasive
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationQOF indicator area: Chronic Obstructive Pulmonary disease (COPD)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Chronic Obstructive Pulmonary Disease QOF indicator area:
More informationVA/DoD Clinical Practice Guideline Management of COPD Pocket Guide
VA/DoD Clinical Practice Guideline Management of COPD Pocket Guide MODULE A: MAAGEMET OF COPD 1 2 Patient with suspected or confirmed COPD presents to primary care [ A ] See sidebar A Perform brief clinical
More informationChapter 11: Respiratory Emergencies
29698_CH11_ANS_p001_005 4/12/05 2:02 PM Page 1 Answer Key Chapter 11 1 Chapter 11: Respiratory Emergencies Matching 1. B (page 373) 8. E (page 370) 2. D (page 369) 9. M(page 389) 3. H (page 370) 10. A
More informationA preliminary assessment of nurses asthma education needs and the effect of a training. programme in an urban tertiary healthcare facility.
A preliminary assessment of nurses asthma education needs and the effect of a training programme in an urban tertiary healthcare facility O O Adeyeye, Y A Kuyinu, R T Bamisile, and C I Oghama Abstract
More informationNew data from the Centers for Disease
MANAGEMENT OF ASTHMA IN THE UNITED STATES: WHERE DO WE STAND? William J. Calhoun, MD ABSTRACT One of the most common respiratory diseases, asthma has been extensively studied. With increases in knowledge
More informationAsthma. Asthma Burden and Best Practices for Children with Asthma. Oregon Asthma Program
Asthma Asthma Burden and Best Practices for Children with Asthma Oregon Asthma Program What is Asthma Data Risk factors Best Practices: Guidelines-based self-management education Oregon Asthma Program
More informationAsthma in a Minute: Tool Kit for asthma self-management education
Asthma in a Minute: Tool Kit for asthma self-management education School Nurses can teach key asthma lessons, one minute at a time Dottie Bardon, BSN, MEd, RN, NCSN LaSalle Springs Middle School Rockwood
More informationAsthma/wheeze management plan
Asthma/wheeze management plan Name of Patient Date of Birth NHS Number GP surgery Telephone Next appointment Children s Assessment unit/ward telephone Out of hours call 111 Open access Y/N Until date Some
More informationOBSERVATION UNIT ASTHMA PATHWAY OUTLINE Westmoreland Hospital PAGE 1 OF 5
PAGE 1 OF 5 Exclusion Criteria: (Reason to admit to hospital) A. New EKG changes except sinus tachycardia B. Respiratory Rate > 40 C. Signs/symptoms of Heart Failure D. Impending respiratory failure or
More informationExercise-Induced Bronchospasm. Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute
Exercise-Induced Bronchospasm Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute EIB Episodic bronchoconstriction with exercise May be an exacerbation
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis
More informationinformation Chronic Obstructive Pulmonary Disease - COPD (1 of 5) What is COPD? What is going on in my lungs? What are the symptoms of COPD?
information If you need this information in another language or medium (audio, large print, etc) please contact the Patient Advice and Liaison Service (PALS) on 0800 374 208 email: pal.service@ salisbury.nhs.uk.
More informationAsthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015
Asthma: Chronic Management Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015 Global Strategy for Asthma Management and Prevention Evidence-based Implementation
More informationChapter 13. Respiratory Emergencies
Chapter 13 Respiratory Emergencies Introduction Patients often complain about dyspnea. Shortness of breath Symptom of many different conditions Cause can be difficult to determine. Even for physician in
More information